Legend Biotech (LEGN) Other Non-Current Assets (2020 - 2024)
Legend Biotech (LEGN) has disclosed Other Non-Current Assets for 3 consecutive years, with $6.1 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Other Non-Current Assets rose 305.63% year-over-year to $6.1 million, compared with a TTM value of $6.1 million through Dec 2024, up 305.63%, and an annual FY2024 reading of $6.1 million, up 305.63% over the prior year.
- Other Non-Current Assets was $6.1 million for Q4 2024 at Legend Biotech, up from $1.5 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $17.3 million in Q4 2021 and bottomed at $1.5 million in Q4 2023.
- Average Other Non-Current Assets over 3 years is $8.3 million, with a median of $6.1 million recorded in 2024.
- Peak annual rise in Other Non-Current Assets hit 305.63% in 2024, while the deepest fall reached 305.63% in 2024.
- Year by year, Other Non-Current Assets stood at $17.3 million in 2021, then crashed by 91.35% to $1.5 million in 2023, then surged by 305.63% to $6.1 million in 2024.
- Business Quant data shows Other Non-Current Assets for LEGN at $6.1 million in Q4 2024, $1.5 million in Q4 2023, and $17.3 million in Q4 2021.